Yogesh Mudras, Managing Director of Informa Markets India: “The expansion of CPHI PMEC India to a two-venue format is a direct response to the scale and complexity that the pharmaceutical industry has reached today. Over the years, CPHI & PMEC India has grown in alignments with the pharma sector, but physical limitations began to constrain the ability of exhibitors – particularly those in machinery and advanced technologies – to fully demonstrate their capabilities. By expanding the show across two venues, we are enabling sharper zoning by product profiles, thereby improving discoverability and relevance. Additionally, the overlapping schedules effectively transform the event into a four-day engagement cycle, allowing deeper and more sustained business interactions. At its core, this expansion is about building a platform that reflects India’s growing global influence in pharmaceuticals: one that seamlessly integrates the entire value chain, from raw materials and APIs to formulations, packaging, and machinery, while reinforcing India’s role as a critical hub for global pharma innovation and manufacturing excellence.”